AstraZeneca will start to supply the European Union with an additional 9 million doses of its vaccine after Europe approved its use to …
AstraZeneca Plc’s and Daiichi Sankyo Co Ltd.’s drug Enhertu (trastuzumab) has won approval in the US to be used in the treatment of advanced …
Amgen (AMGN) and AstraZeneca (AZN) have announced positive topline results from the Phase 3 Navigator trial for tezepelumab, which demonstrated a statistically significant …
AstraZeneca announced that the US regulator has approved its heart treatment Brilinta to be used to reduce the risk of an attack in …
AstraZeneca will present late-stage trial data for its Covid-19 vaccine candidate later this year as the UK drugmaker said it is on track …
AstraZeneca on Friday announced that it would sell the commercial rights to two hypertension medicines, Atacand and Atacand Plus, to German pharmaceutical company …
Astrazeneca Pharmaceuticals (AZN) has been awarded a $286.9 milllion firm-fixed-price contract for the delivery of 200 million doses of AZD1222 vaccine for COVID- …
AstraZeneca announced on Friday that the US Food and Drug Administration (FDA) has authorized the restart of the US late-stage trial of AZD1222, …
A Brazilian volunteer taking part in a COVID-19 clinical trial by AstraZeneca and Oxford University has died, Reuters reported citing data from the …
AstraZeneca’s US Covid-19 vaccine trial is poised to resume as early as this week after the US Food and Drug Administration completed its …
